These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7544049)

  • 1. Most of the VP1 unique region of B19 parvovirus is on the capsid surface.
    Kawase M; Momoeda M; Young NS; Kajigaya S
    Virology; 1995 Aug; 211(2):359-66. PubMed ID: 7544049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unique region of the minor capsid protein of human parvovirus B19 is exposed on the virion surface.
    Rosenfeld SJ; Yoshimoto K; Kajigaya S; Anderson S; Young NS; Field A; Warrener P; Bansal G; Collett MS
    J Clin Invest; 1992 Jun; 89(6):2023-9. PubMed ID: 1376332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formation of empty B19 parvovirus capsids by the truncated minor capsid protein.
    Wong S; Momoeda M; Field A; Kajigaya S; Young NS
    J Virol; 1994 Jul; 68(7):4690-4. PubMed ID: 8207846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B cell memory is directed toward conformational epitopes of parvovirus B19 capsid proteins and the unique region of VP1.
    Corcoran A; Mahon BP; Doyle S
    J Infect Dis; 2004 May; 189(10):1873-80. PubMed ID: 15122524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conformational changes in the VP1-unique region of native human parvovirus B19 lead to exposure of internal sequences that play a role in virus neutralization and infectivity.
    Ros C; Gerber M; Kempf C
    J Virol; 2006 Dec; 80(24):12017-24. PubMed ID: 17020940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Follow-up study of clinical and immunological findings in patients presenting with acute parvovirus B19 infection.
    Kerr JR; Coyle PV; DeLeys RJ; Patterson CC
    J Med Virol; 1996 Jan; 48(1):68-75. PubMed ID: 8825713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification and analysis of polyhistidine-tagged human parvovirus B19 VP1 and VP2 expressed in insect cells.
    Michel PO; Mäkelä AR; Korhonen E; Toivola J; Hedman L; Söderlund-Venermo M; Hedman K; Oker-Blom C
    J Virol Methods; 2008 Sep; 152(1-2):1-5. PubMed ID: 18598721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chimeric parvovirus B19 capsids for the presentation of foreign epitopes.
    Brown CS; Welling-Wester S; Feijlbrief M; Van Lent JW; Spaan WJ
    Virology; 1994 Feb; 198(2):477-88. PubMed ID: 7507280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the cell and erythrocyte binding activities of the dimple and canyon regions of the canine parvovirus capsid.
    Tresnan DB; Southard L; Weichert W; Sgro JY; Parrish CR
    Virology; 1995 Aug; 211(1):123-32. PubMed ID: 7645206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subunit interaction in B19 parvovirus empty capsids.
    Rosenfeld SJ; Young NS; Alling D; Ayub J; Saxinger C
    Arch Virol; 1994; 136(1-2):9-18. PubMed ID: 7516147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parvovirus particles as platforms for protein presentation.
    Miyamura K; Kajigaya S; Momoeda M; Smith-Gill SJ; Young NS
    Proc Natl Acad Sci U S A; 1994 Aug; 91(18):8507-11. PubMed ID: 8078912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T-helper cell-mediated interferon-gamma, interleukin-10 and proliferation responses to a candidate recombinant vaccine for human parvovirus B19.
    Franssila R; Hedman K
    Vaccine; 2004 Sep; 22(27-28):3809-15. PubMed ID: 15315862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-assembled B19 parvovirus capsids, produced in a baculovirus system, are antigenically and immunogenically similar to native virions.
    Kajigaya S; Fujii H; Field A; Anderson S; Rosenfeld S; Anderson LJ; Shimada T; Young NS
    Proc Natl Acad Sci U S A; 1991 Jun; 88(11):4646-50. PubMed ID: 1711206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgG immune response to B19 parvovirus VP1 and VP2 linear epitopes by immunoblot assay.
    Manaresi E; Gallinella G; Zerbini M; Venturoli S; Gentilomi G; Musiani M
    J Med Virol; 1999 Feb; 57(2):174-8. PubMed ID: 9892404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parvovirus B19 VP2-proteins produced in Saccharomyces cerevisiae: comparison with VP2-particles produced by baculovirus-derived vectors.
    Lowin T; Raab U; Schroeder J; Franssila R; Modrow S
    J Vet Med B Infect Dis Vet Public Health; 2005; 52(7-8):348-52. PubMed ID: 16316399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of parvovirus B19 NS1-specific antibodies by ELISA and western blotting employing recombinant NS1 protein as antigen.
    Heegaard ED; Rasksen CJ; Christensen J
    J Med Virol; 2002 Jul; 67(3):375-83. PubMed ID: 12116031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formation of immunogenic virus-like particles by inserting epitopes into surface-exposed regions of hamster polyomavirus major capsid protein.
    Gedvilaite A; Frömmel C; Sasnauskas K; Micheel B; Ozel M; Behrsing O; Staniulis J; Jandrig B; Scherneck S; Ulrich R
    Virology; 2000 Jul; 273(1):21-35. PubMed ID: 10891404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human parvovirus B19 VP2 empty capsids bind to human villous trophoblast cells in vitro via the globoside receptor.
    Wegner CC; Jordan JA
    Infect Dis Obstet Gynecol; 2004 Jun; 12(2):69-78. PubMed ID: 15739820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Canine parvovirus capsid assembly and differences in mammalian and insect cells.
    Yuan W; Parrish CR
    Virology; 2001 Jan; 279(2):546-57. PubMed ID: 11162810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chimeric virus-like particle formation of adeno-associated virus.
    Hoque M; Shimizu N; Ishizu Ki; Yajima H; Arisaka F; Suzuki K; Watanabe H; Handa H
    Biochem Biophys Res Commun; 1999 Dec; 266(2):371-6. PubMed ID: 10600510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.